Magnetic study on biodistribution and biodegradation of oral magnetic nanostructures in the rat gastrointestinal tract
Source abstract
Abstract
We have undertaken a magnetic study on the oral biodistribution and biodegradation of nude maghemite nanoparticles of 10 nm average size (MNP) and probiotic bacteria, Lactobacillus fermentum, containing thousands of these same nanoparticles (MNP-bacteria). Using AC magnetic susceptibility measurements of the stomach, small intestine, cecum and large intestine obtained after rat sacrifice, and iron content determination by ICP-OES, we have monitored the biodistribution and biodegradation of the maghemite nanoparticles along the gastrointestinal tract, after oral administration of both MNP and MNP-bacteria. The results revealed that the amount of magnetic nanoparticles accumulated in intestines is sensibly higher when MNP-bacteria were administered, in comparison with MNP. This confirms our initial hypothesis that the use of probiotic bacteria is a suitable strategy to assist the magnetic nanoparticles to overcome the stomach medium, and to achieve their accumulation in intestines. This finding opens doors to different applications. Since iron absorption in humans takes place precisely in the intestines, the use of MNP-bacteria as an iron supplement is a definite possibility. We have actually illustrated how the administration of MNP-bacteria to iron-deficient rats corrects the iron levels after two weeks of treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Magnetic and Electromagnetic Effects · Geomagnetism and Paleomagnetism Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (23)
Show source-provided references
1. S. Laurent , L.Vander Elst and R. N.Muller, in Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging, ed. A. Merbach, L. Helm and E. Toth, 2nd edn, 2013, pp. 427–447
2. Liu · Nanomedicine · 2011 · 6 · 51910.2217/nnm.11.16 ↗
3. Laurent · Future Med. Chem. · 2010 · 2 · 42710.4155/fmc.09.164 ↗
4. Laurent · Chem. Rev. · 2009 · 110 · 257410.1021/cr900197g ↗
5. Titinchi · Adv. Healthcare Mater. · 2014 · 3 · 4910.1002/9781118774205.ch3 ↗
6. Canfarotta · Adv. Healthcare Mater. · 2014 · 3 · 16010.1002/adhm.201300141 ↗
7. Colombo · Chem. Soc. Rev. · 2012 · 41 · 430610.1039/c2cs15337h ↗
8. Pankhurst · J. Phys. D: Appl. Phys. · 2009 · 42 · 22400110.1088/0022-3727/42/22/224001 ↗
9. Kolosnjaj-Tabi · Nano Today · 2016 · 11 · 28010.1016/j.nantod.2015.10.001 ↗
10. Chamorro · Nanotechnology · 2015 · 26 · 20510110.1088/0957-4484/26/20/205101 ↗
11. P. Guardia , A.Riedinger, H.Kakwere, F.Gazeau and T.Pellegrino, in Bio- and Bioinspired Nanomaterials, ed. D. Ruiz-Molina, F. Novio and C. Roscini, 2015, pp. 139–172
12. Liu · ACS Nano · 2014 · 8 · 1129010.1021/nn5040923 ↗
13. McLean · Public Health Nutr. · 2009 · 12 · 44410.1017/S1368980008002401 ↗
14. R. Hoffman , E.Benz and S.Shattil, et al., Disorders of iron metabolism: iron deficiency and overload, in Hematology, Churchill Livingstone, Philadelphia-USA, Harcourt Brace & Co, New York, NY, USA, 3rd edn, 2000, ch. 26
15. Martín · Adv. Funct. Mater. · 2014 · 24 · 348910.1002/adfm.201303754 ↗
16. Gutiérrez · Phys. Chem. Chem. Phys. · 2014 · 16 · 445610.1039/C3CP54763A ↗
17. Gutiérrez · Biomed. Tech. · 2015 · 60 · 41710.1515/bmt-2015-0043 ↗
18. Carmona · Inorg. Chem. · 2014 · 53 · 856510.1021/ic501146r ↗
19. Massart · IEEE Trans. Magn. · 1981 · 124710.1109/TMAG.1981.1061188 ↗
20. Vayssieres · J. Colloid Interface Sci. · 1998 · 205 · 20510.1006/jcis.1998.5614 ↗
21. Kilkenny · J. Pharmacol. Pharmacother. · 2010 · 1 · 9410.4103/0976-500X.72351 ↗
22. McGrath · Br. J. Pharmacol. · 2010 · 160 · 157310.1111/j.1476-5381.2010.00873.x ↗
23. López · Phys. Med. Biol. · 2007 · 52 · 504310.1088/0031-9155/52/16/022 ↗